metoclopramide has been researched along with Basal Ganglia Diseases in 57 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The potent serotonin receptor (5-HT3) antagonists are new highly selective agents for the prevention and control of chemotherapy-induced nausea and vomiting that have been shown to be comparable to or more effective than traditional metoclopramide regimens." | 9.08 | A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy. ( Bastit, P; Cals, L; Cappelaere, P; Catimel, G; Chevallier, B; Claverie, N; Fabbro, M; Giovannini, M; Khayat, D; Splinter, T; Wendling, JL, 1997) |
| "To report 2 cases of serotonin syndrome with serious extrapyramidal movement disorders occurring when metoclopramide was coadministered with sertraline or venlafaxine." | 7.71 | Serotonin syndrome caused by selective serotonin reuptake-inhibitors-metoclopramide interaction. ( Davis, MW; Fisher, AA, 2002) |
| "We have reported the case of a 58-year-old woman with cerebral palsy who experienced a persistent, generalized syndrome of dystonia and rigidity (tardive dystonia-parkinsonism) while being treated for vomiting with metoclopramide in combination with prochlorperazine." | 7.68 | Persistent extrapyramidal syndrome with dystonia and rigidity caused by combined metoclopramide and prochlorperazine therapy. ( Factor, SA; Matthews, MK, 1991) |
| " Dosage of these two drugs were 450 = 133 mg and 32 +/- 9." | 6.67 | [A double-blind study of metoclopramide in the treatment of schizophrenia and determination of prolactin]. ( Gu, SF, 1992) |
| "Metoclopramide, 4-amino-5-chloro-2-methoxy-N-(2-diethyl-aminoethyl) benzamide, is advocated for use in gastro-intestinal diagnostics, and in treating various types of vomiting and a variety of functional and organic gastro-intestinal disorders." | 6.14 | Metoclopramide: a review of its pharmacological properties and clinical use. ( Avery, GS; Brogden, RN; Pinder, RM; Sawyer, PR; Speight, TM, 1976) |
| " The quantitative dose-response curves of the four doses of the emetic agonist cisplatin were shifted to the right by increasing doses of MCL." | 5.27 | Dose-response relationships of the objective and subjective antiemetic effects and of different side effects of metoclopramide against cisplatin induced emesis. ( Hellenbrecht, D; Saller, R, 1986) |
| "Metoclopramide (Paspertin) was infused intravenously in the high doses of 1." | 5.27 | Improved benefit/risk ratio of higher-dose metoclopramide therapy during cisplatin-induced emesis. ( Hellenbrecht, D; Hellstern, A; Hess, H; Saller, R, 1985) |
| "The potent serotonin receptor (5-HT3) antagonists are new highly selective agents for the prevention and control of chemotherapy-induced nausea and vomiting that have been shown to be comparable to or more effective than traditional metoclopramide regimens." | 5.08 | A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy. ( Bastit, P; Cals, L; Cappelaere, P; Catimel, G; Chevallier, B; Claverie, N; Fabbro, M; Giovannini, M; Khayat, D; Splinter, T; Wendling, JL, 1997) |
| "To report 2 cases of serotonin syndrome with serious extrapyramidal movement disorders occurring when metoclopramide was coadministered with sertraline or venlafaxine." | 3.71 | Serotonin syndrome caused by selective serotonin reuptake-inhibitors-metoclopramide interaction. ( Davis, MW; Fisher, AA, 2002) |
| " Metoclopramide-treated patients had significantly greater severity of tardive dyskinesia, drug-induced parkinsonism, and subjective akathisia than controls." | 3.68 | The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. ( Casey, DE; Ganzini, L; Hoffman, WF; McCall, AL, 1993) |
| "We have reported the case of a 58-year-old woman with cerebral palsy who experienced a persistent, generalized syndrome of dystonia and rigidity (tardive dystonia-parkinsonism) while being treated for vomiting with metoclopramide in combination with prochlorperazine." | 3.68 | Persistent extrapyramidal syndrome with dystonia and rigidity caused by combined metoclopramide and prochlorperazine therapy. ( Factor, SA; Matthews, MK, 1991) |
| "We present extrapyramidal syndrome in 22 children (5 en 1984 and 17 during 1985) who received clebopride (15), metoclopramide (6) and haloperidol (1), almost all at the level of therapeutic doses, which fact seems to indicated a idiosyncratic factor." | 3.67 | [Drug-induced extrapyramidal syndrome. Apropos of 22 cases]. ( Calvo Fernández, J; Castro-Gago, M; Couce Pico, M; López Rois, F; Novo, I, 1987) |
| "The authors, by reference to a patient showing acathisia and other dyskinetic disorders following the administration to him of small doses of metoclopramide (Cerucal) and clomipramine, which is a thymoleptic, discuss extrapyramidal disorders attendant upon the therapy of larvated depressions or depressions accompanied by gastrointestinal disorders." | 3.65 | [Metoclopramide (Cerucal) side-effects in the form of extrapyramidal disorders in combination with an other antidepressive agent]. ( Felber, W; Ficker, F, 1977) |
| " Dosage of these two drugs were 450 = 133 mg and 32 +/- 9." | 2.67 | [A double-blind study of metoclopramide in the treatment of schizophrenia and determination of prolactin]. ( Gu, SF, 1992) |
| " To prevent persistent and disabling movement disorders, long-term use of metoclopramide should be avoided, and patients should be carefully observed for potential neurologic reactions." | 2.38 | Metoclopramide-induced movement disorders. Clinical findings with a review of the literature. ( Jankovic, J; Miller, LG, 1989) |
| "Metoclopramide is a useful medication in the anesthesia provider's armamentarium." | 1.35 | Metoclopramide and extrapyramidal symptoms: a case report. ( Hansen, DJ; Moos, DD, 2008) |
| " Although adverse reactions are rare, a potential exists for extrapyramidal side effects to occur." | 1.29 | Extrapyramidal side effects of metoclopramide in outpatient surgery patients. ( Dziura-Murauski, J; Holesha, W, 1994) |
| " The quantitative dose-response curves of the four doses of the emetic agonist cisplatin were shifted to the right by increasing doses of MCL." | 1.27 | Dose-response relationships of the objective and subjective antiemetic effects and of different side effects of metoclopramide against cisplatin induced emesis. ( Hellenbrecht, D; Saller, R, 1986) |
| " Before studying the efficacy of MCP as an antiemetic in children, we first had to establish the safe dose range." | 1.27 | Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy. ( Allen, JC; Gralla, R; Kellick, M; Reilly, L; Young, C, 1985) |
| "Metoclopramide (Paspertin) was infused intravenously in the high doses of 1." | 1.27 | Improved benefit/risk ratio of higher-dose metoclopramide therapy during cisplatin-induced emesis. ( Hellenbrecht, D; Hellstern, A; Hess, H; Saller, R, 1985) |
| "Metoclopramide is known to produce three froms of extrapyramidal and motor side effects, namely: 1." | 1.26 | [Extrapyramidal syndromes as side-effects of metoclopramide (Cerucal) medication]. ( Decke, D; Felber, W; Kunath, B; Papperitz, V, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (54.39) | 18.7374 |
| 1990's | 18 (31.58) | 18.2507 |
| 2000's | 6 (10.53) | 29.6817 |
| 2010's | 1 (1.75) | 24.3611 |
| 2020's | 1 (1.75) | 2.80 |
| Authors | Studies |
|---|---|
| Piana, F | 1 |
| Minghella, E | 1 |
| Cavero-Redondo, I | 1 |
| Álvarez-Bueno, C | 1 |
| Pozuelo-Carrascosa, DP | 1 |
| Díez-Fernández, A | 1 |
| Notario-Pacheco, B | 1 |
| Moos, DD | 1 |
| Hansen, DJ | 1 |
| Ohno, K | 1 |
| Miyazawa, S | 1 |
| Hashiguchi, M | 1 |
| Unemoto, T | 1 |
| Itoh, A | 1 |
| Echizen, H | 1 |
| Rikihisa, T | 1 |
| Ogata, H | 1 |
| Murata, M | 1 |
| Martín Jiménez, M | 1 |
| Díaz-Rubio García, E | 1 |
| Castellón Leal, E | 1 |
| Sánchez Sobrino, M | 1 |
| Aapro, MS | 1 |
| Plezia, PM | 1 |
| Alberts, DS | 1 |
| Graham, V | 1 |
| Jones, SE | 1 |
| Surwit, EA | 1 |
| Moon, TE | 1 |
| Strum, SB | 1 |
| McDermed, JE | 1 |
| Ell, C | 1 |
| König, HJ | 1 |
| Wässer, S | 1 |
| Acharya, SR | 1 |
| Kumar, TN | 1 |
| Vasshadhara, C | 1 |
| Low, LC | 1 |
| Goel, KM | 1 |
| Inkpen, T | 1 |
| Carey, MJ | 1 |
| Aitken, ME | 1 |
| Skewes, A | 2 |
| Holesha, W | 1 |
| Dziura-Murauski, J | 1 |
| Ganzini, L | 1 |
| Casey, DE | 1 |
| Hoffman, WF | 1 |
| McCall, AL | 1 |
| Deutch, AY | 1 |
| Lewis, DA | 1 |
| Whitehead, RE | 1 |
| Elsworth, JD | 1 |
| Iadarola, MJ | 1 |
| Redmond, DE | 1 |
| Roth, RH | 1 |
| Christensen, RC | 1 |
| Byerly, MJ | 1 |
| Chevallier, B | 1 |
| Cappelaere, P | 1 |
| Splinter, T | 1 |
| Fabbro, M | 1 |
| Wendling, JL | 1 |
| Cals, L | 1 |
| Catimel, G | 1 |
| Giovannini, M | 1 |
| Khayat, D | 1 |
| Bastit, P | 1 |
| Claverie, N | 1 |
| Stille, CJ | 1 |
| Poorter, ME | 1 |
| Wolf, BH | 1 |
| Woltil, HA | 1 |
| Warren, J | 1 |
| Thompson, P | 1 |
| Sahìn, B | 1 |
| Türkmen, MA | 1 |
| Kavukçu, S | 1 |
| Fisher, AA | 1 |
| Davis, MW | 1 |
| Sow, A | 1 |
| Ba, A | 1 |
| Diop Mar, I | 1 |
| Tobolka-Christian, G | 1 |
| Pinder, RM | 1 |
| Brogden, RN | 1 |
| Sawyer, PR | 1 |
| Speight, TM | 1 |
| Avery, GS | 1 |
| Babić, K | 1 |
| Borcić, D | 1 |
| Beus, A | 1 |
| Ficker, F | 1 |
| Felber, W | 2 |
| Khalil, R | 1 |
| Ali Cherif, A | 1 |
| Vigouroux, RA | 1 |
| Boudouresques, G | 1 |
| Kunath, B | 1 |
| Papperitz, V | 1 |
| Decke, D | 1 |
| Melmed, S | 1 |
| Bank, H | 1 |
| Pycock, C | 1 |
| Tarsy, D | 1 |
| Marsden, CD | 1 |
| Gu, SF | 1 |
| Smith, M | 1 |
| Darnell, JD | 1 |
| Rodgers, C | 1 |
| Casteels-Van Daele, M | 1 |
| Il'iash, TI | 1 |
| Laskarzhevskaia, NM | 1 |
| Sethi, KD | 1 |
| Zamrini, EY | 1 |
| Factor, SA | 1 |
| Matthews, MK | 1 |
| Bateman, DN | 1 |
| Darling, WM | 1 |
| Boys, R | 1 |
| Rawlins, MD | 1 |
| Miller, LG | 1 |
| Jankovic, J | 1 |
| Hollander, H | 1 |
| Golden, J | 1 |
| Mendelson, T | 1 |
| Cortland, D | 1 |
| Pall, HS | 1 |
| Williams, AC | 1 |
| Santos, A | 1 |
| Arana, G | 1 |
| Boulloche, J | 1 |
| Mallet, E | 1 |
| Mouterde, O | 1 |
| Tron, P | 1 |
| Craig, JB | 1 |
| Powell, BL | 1 |
| White, DR | 1 |
| Capizzi, RL | 1 |
| López Rois, F | 1 |
| Couce Pico, M | 1 |
| Calvo Fernández, J | 1 |
| Novo, I | 1 |
| Castro-Gago, M | 1 |
| Hellenbrecht, D | 2 |
| Saller, R | 2 |
| Levitskaia, SV | 1 |
| Freĭdkov, VI | 1 |
| Allen, JC | 1 |
| Gralla, R | 1 |
| Reilly, L | 1 |
| Kellick, M | 1 |
| Young, C | 1 |
| Chouza, C | 1 |
| Caamano, JL | 1 |
| Romero, S | 1 |
| Lorenzo, J | 1 |
| Feres, S | 1 |
| Hellstern, A | 1 |
| Hess, H | 1 |
| De Silva, KL | 1 |
| Muller, PJ | 1 |
| Pearce, J | 1 |
| Robinson, OP | 1 |
5 reviews available for metoclopramide and Basal Ganglia Diseases
| Article | Year |
|---|---|
Risk of extrapyramidal side effects comparing continuous vs. bolus intravenous metoclopramide administration: a systematic review and meta-analysis of randomised controlled trials.
Topics: Antiemetics; Basal Ganglia Diseases; Humans; Infusions, Intravenous; Injections, Intravenous; Metocl | 2015 |
Metoclopramide: a review of its pharmacological properties and clinical use.
Topics: Animals; Basal Ganglia Diseases; Cardiovascular System; Central Nervous System; Clinical Trials as T | 1976 |
[Extrapyramidal disorders occurring after taking cerucal].
Topics: Adolescent; Basal Ganglia Diseases; Emergencies; Female; Humans; Metoclopramide | 1991 |
Metoclopramide-induced movement disorders. Clinical findings with a review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Female; Humans; Ma | 1989 |
Metaclopramide neurotoxicity.
Topics: Acute Disease; Aged; Basal Ganglia Diseases; Diagnosis, Differential; Duodenal Ulcer; Dyskinesia, Dr | 1988 |
6 trials available for metoclopramide and Basal Ganglia Diseases
| Article | Year |
|---|---|
Establishing a comprehensive questionnaire for detecting drug-induced extrapyramidal symptoms.
Topics: Aged; Basal Ganglia Diseases; Benzamides; Benzyl Compounds; Cisapride; Domperidone; Dopamine Antagon | 2003 |
Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide.
Topics: Adult; Aged; Antiemetics; Basal Ganglia Diseases; Cisplatin; Dexamethasone; Double-Blind Method; Dru | 1984 |
A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy.
Topics: Acute Disease; Alcoholism; Antiemetics; Antineoplastic Agents; Basal Ganglia Diseases; Cisplatin; Do | 1997 |
Metoclopramide: a review of its pharmacological properties and clinical use.
Topics: Animals; Basal Ganglia Diseases; Cardiovascular System; Central Nervous System; Clinical Trials as T | 1976 |
[A double-blind study of metoclopramide in the treatment of schizophrenia and determination of prolactin].
Topics: Adolescent; Adult; Basal Ganglia Diseases; Double-Blind Method; Female; Haloperidol; Humans; Male; M | 1992 |
Antiemetic therapy in patients treated with high-dose cytosine arabinoside.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Clinical Trials as Topic; Cytarabine; Drug Therapy, | 1987 |
47 other studies available for metoclopramide and Basal Ganglia Diseases
| Article | Year |
|---|---|
Extrapyramidal signs following a single intravenous dose of metoclopramide in an English Bulldog.
Topics: Administration, Intravenous; Animals; Antiemetics; Basal Ganglia Diseases; Dog Diseases; Dogs; Metoc | 2021 |
Metoclopramide and extrapyramidal symptoms: a case report.
Topics: Adjuvants, Anesthesia; Adult; Basal Ganglia Diseases; Humans; Male; Metoclopramide; Practice Guideli | 2008 |
Extrapyramidal reactions to SSRI antidepressant + neuroleptic combinations.
Topics: Antidepressive Agents; Antipsychotic Agents; Basal Ganglia Diseases; Drug Interactions; Drug Therapy | 2004 |
Metoclopramide: extrapyramidal symptoms in children.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Child; Humans; Metoclopramide; Nausea; Netherlands; Vo | 2007 |
[Extrapyramidal reactions induced by intravenous metoclopramide].
Topics: Adult; Aged; Basal Ganglia Diseases; Female; Humans; Infusions, Parenteral; Male; Metoclopramide; Mi | 1984 |
Treatment of side effects in patients receiving Iv metoclopramide.
Topics: Adult; Basal Ganglia Diseases; Dose-Response Relationship, Drug; Humans; Metoclopramide | 1983 |
[Extrapyramidal reactions caused by large doses of metoclopramide].
Topics: Adult; Aged; Basal Ganglia Diseases; Dose-Response Relationship, Drug; Humans; Metoclopramide; Middl | 1984 |
[Making a diagnosis. Side effects of metoclopramide].
Topics: Attention Deficit Disorder with Hyperactivity; Basal Ganglia Diseases; Biperiden; Child; Humans; Mal | 1982 |
Metoclopramide--a cholinomimetic tremorogen?
Topics: Animals; Basal Ganglia Diseases; Dogs; Guinea Pigs; Humans; Metoclopramide; Parasympathetic Nervous | 1982 |
Metoclopramide poisoning in children.
Topics: Basal Ganglia Diseases; Child; Child, Preschool; Female; Humans; Infant; Male; Metoclopramide | 1980 |
Metoclopramide-induced extrapyramidal syndromes.
Topics: Basal Ganglia Diseases; Carcinoma, Renal Cell; Dexamethasone; Female; Humans; Kidney Neoplasms; Meto | 1993 |
Diverse effects of antiemetics in children.
Topics: Antiemetics; Basal Ganglia Diseases; Child; Child, Preschool; Drug Overdose; Female; Gastroenteritis | 1994 |
Further information available on extrapyramidal symptoms.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Female; Humans; Metoclopramide | 1993 |
Extrapyramidal side effects of metoclopramide in outpatient surgery patients.
Topics: Adult; Aged; Ambulatory Surgical Procedures; Basal Ganglia Diseases; Female; Humans; Male; Metoclopr | 1994 |
The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
Topics: Adult; Aged; Aged, 80 and over; Akathisia, Drug-Induced; Basal Ganglia Diseases; Diabetes Complicati | 1993 |
Effects of D2 dopamine receptor antagonists on Fos protein expression in the striatal complex and entorhinal cortex of the nonhuman primate.
Topics: Animals; Basal Ganglia Diseases; Caudate Nucleus; Chlorocebus aethiops; Dopamine Antagonists; Dopami | 1996 |
Mandibular dystonia associated with the combination of sertraline and metoclopramide.
Topics: 1-Naphthylamine; Adult; Basal Ganglia Diseases; Depressive Disorder; Drug Interactions; Dystonia; Fe | 1996 |
Index of Suspicion. Case 1. Dystonic reaction to metoclopramide.
Topics: Antiemetics; Basal Ganglia Diseases; Dystonia Musculorum Deformans; Gastroesophageal Reflux; Humans; | 1997 |
[A 'suppository for vomiting prevention'].
Topics: Antiemetics; Basal Ganglia Diseases; Child; Child, Preschool; Diagnosis, Differential; Domperidone; | 1997 |
Drug-induced supraglottic dystonia and spasmodic dysphonia.
Topics: Aged; Antiemetics; Basal Ganglia Diseases; Droperidol; Dystonia; Female; Humans; Metoclopramide; Tri | 1998 |
Iatrogenic metoclopramide toxicity in an infant presenting to a pediatric emergency department.
Topics: Basal Ganglia Diseases; Dopamine Antagonists; Drug Overdose; Emergency Service, Hospital; Female; Hu | 2001 |
Serotonin syndrome caused by selective serotonin reuptake-inhibitors-metoclopramide interaction.
Topics: Accidental Falls; Adult; Aged; Basal Ganglia Diseases; Cyclohexanols; Depressive Disorder; Dopamine | 2002 |
[Rare and unusual drug intolerances, apropos of 6 cases].
Topics: Adolescent; Adult; Basal Ganglia Diseases; Chemical and Drug Induced Liver Injury; Child; Drug Hyper | 1977 |
[Extrapyramidal signs as side-effect with metoclopramid-medication (author's transl)].
Topics: Age Factors; Basal Ganglia Diseases; Child; Child, Preschool; Female; Humans; Male; Metoclopramide | 1978 |
[Extrapyramidal syndrome as a side-effect of treatment with thiethylperazine (torecan) and metoclopramide (Reglan) a review of ten cases (author's transl)].
Topics: Adolescent; Adult; Basal Ganglia Diseases; Child; Child, Preschool; Female; Humans; Male; Metoclopra | 1977 |
[Metoclopramide (Cerucal) side-effects in the form of extrapyramidal disorders in combination with an other antidepressive agent].
Topics: Adult; Basal Ganglia Diseases; Clomipramine; Depression; Drug Combinations; Female; Gastrointestinal | 1977 |
[Letter: Extrapyramidal syndrome and metoclopramide].
Topics: Adolescent; Adult; Basal Ganglia Diseases; Female; Humans; Male; Metoclopramide | 1976 |
[Extrapyramidal syndromes as side-effects of metoclopramide (Cerucal) medication].
Topics: Adult; Aged; Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Female; Humans; Hyperkinesis; Male; M | 1976 |
Letter: Metoclopramide and facial dyskinesia.
Topics: Adult; Basal Ganglia Diseases; Face; Facial Expression; Female; Humans; Male; Metoclopramide; Moveme | 1975 |
Inhibition of circling behavior by neuroleptic drugs in mice with unilateral 6-hydroxydopamine lesions of the striatum.
Topics: Animals; Apomorphine; Basal Ganglia Diseases; Behavior; Biogenic Amines; Bis(4-Methyl-1-Homopiperazi | 1975 |
In pursuit of nursing excellence.
Topics: Adult; Aged; Aged, 80 and over; Analgesia, Patient-Controlled; Arthritis; Basal Ganglia Diseases; Co | 1992 |
Extrapyramidal side effects of antiemetics presenting as psychiatric illness.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Akathisia, Drug-Induced; Antiemetics; Anxiety Disor | 1992 |
Reye syndrome or side-effects of anti-emetics?
Topics: Antiemetics; Aspirin; Basal Ganglia Diseases; Bias; Child; Cytomegalovirus Infections; Diagnosis, Di | 1991 |
Asymmetry in clinical features of drug-induced parkinsonism.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Dominance, Cerebral; Female; Humans; Male | 1990 |
Persistent extrapyramidal syndrome with dystonia and rigidity caused by combined metoclopramide and prochlorperazine therapy.
Topics: Basal Ganglia Diseases; Cerebral Palsy; Dystonia; Female; Humans; Intellectual Disability; Metoclopr | 1991 |
Extrapyramidal reactions to metoclopramide and prochlorperazine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Akathisia, Drug-Induced; Basal Ganglia Diseases; Child; | 1989 |
Extrapyramidal symptoms in AIDS patients given low-dose metoclopramide or chlorpromazine.
Topics: Acquired Immunodeficiency Syndrome; Basal Ganglia Diseases; Chlorpromazine; Drug Administration Sche | 1985 |
Extrapyramidal disturbances caused by inappropriate prescribing.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Female; Humans; Iatrogenic Disease; Male; Metocloprami | 1987 |
Dystonic reactions with metoclopramide: is there a risk population?
Topics: Adolescent; Basal Ganglia Diseases; Child; Child, Preschool; Dystonia; Enteritis; Female; Humans; Ma | 1987 |
[Drug-induced extrapyramidal syndrome. Apropos of 22 cases].
Topics: Adolescent; Antiemetics; Basal Ganglia Diseases; Benzamides; Child; Child, Preschool; Female; Halope | 1987 |
Dose-response relationships of the objective and subjective antiemetic effects and of different side effects of metoclopramide against cisplatin induced emesis.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Cisplatin; Dose-Response Relationship, Drug; Humans | 1986 |
[Side effects of metoclopramide (reglan, cerukal) on the nervous system].
Topics: Basal Ganglia Diseases; Child; Digestive System Diseases; Female; Humans; Male; Metoclopramide | 1986 |
Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy.
Topics: Adolescent; Adult; Akathisia, Drug-Induced; Antineoplastic Agents; Basal Ganglia Diseases; Child; Di | 1985 |
Extrapyramidal effects of benzamides.
Topics: Basal Ganglia Diseases; Benzamides; Dyskinesia, Drug-Induced; Humans; Metoclopramide; Movement Disor | 1985 |
Improved benefit/risk ratio of higher-dose metoclopramide therapy during cisplatin-induced emesis.
Topics: Basal Ganglia Diseases; Cisplatin; Dose-Response Relationship, Drug; Hemodynamics; Humans; Metoclopr | 1985 |
Acute drug-induced extrapyramidal syndromes.
Topics: Adolescent; Adult; Basal Ganglia Diseases; Benztropine; Child; Diagnosis, Differential; Diazepam; Fe | 1973 |
Metoclopramide--side effects and safety.
Topics: Adolescent; Adult; Basal Ganglia Diseases; Child; Child, Preschool; Female; Gastrointestinal Disease | 1973 |